Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population.

IF 14.8 2区 医学 Q1 ONCOLOGY
Sofia Yi, Rutu A Rathod, Vijaya Subbu Natchimuthu, Sheena Bhalla, Jessica L Lee, Travis Browning, Joyce O Adesina, Minh Do, David Balis, Juana Gamarra de Wiliams, Ellen Kitchell, Noel O Santini, David H Johnson, Heidi A Hamann, Simon J Craddock Lee, Amy E Hughes, David E Gerber
{"title":"Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population.","authors":"Sofia Yi, Rutu A Rathod, Vijaya Subbu Natchimuthu, Sheena Bhalla, Jessica L Lee, Travis Browning, Joyce O Adesina, Minh Do, David Balis, Juana Gamarra de Wiliams, Ellen Kitchell, Noel O Santini, David H Johnson, Heidi A Hamann, Simon J Craddock Lee, Amy E Hughes, David E Gerber","doi":"10.6004/jnccn.2023.7112","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recent modifications to low-dose CT (LDCT)-based lung cancer screening guidelines increase the number of eligible individuals, particularly among racial and ethnic minorities. Because these populations disproportionately live in metropolitan areas, we analyzed the association between travel time and initial LDCT completion within an integrated, urban safety-net health care system.</p><p><strong>Methods: </strong>Using Esri's StreetMap Premium, OpenStreetMap, and the r5r package in R, we determined projected private vehicle and public transportation travel times between patient residence and the screening facility for LDCT ordered in March 2017 through December 2022 at Parkland Memorial Hospital in Dallas, Texas. We characterized associations between travel time and LDCT completion in univariable and multivariable analyses. We tested these associations in a simulation of 10,000 permutations of private vehicle and public transportation distribution.</p><p><strong>Results: </strong>A total of 2,287 patients were included in the analysis, of whom 1,553 (68%) completed the initial ordered LDCT. Mean age was 63 years, and 73% were underrepresented minorities. Median travel time from patient residence to the LDCT screening facility was 17 minutes by private vehicle and 67 minutes by public transportation. There was a small difference in travel time to the LDCT screening facility by public transportation for patients who completed LDCT versus those who did not (67 vs 66 min, respectively; P=.04) but no difference in travel time by private vehicle for these patients (17 min for both; P=.67). In multivariable analysis, LDCT completion was not associated with projected travel time to the LDCT facility by private vehicle (odds ratio, 1.01; 95% CI, 0.82-1.25) or public transportation (odds ratio, 1.14; 95% CI, 0.89-1.44). Similar results were noted across travel-type permutations. Black individuals were 29% less likely to complete LDCT screening compared with White individuals.</p><p><strong>Conclusions: </strong>In an urban population comprising predominantly underrepresented minorities, projected travel time is not associated with initial LDCT completion in an integrated health care system. Other reasons for differences in LDCT completion warrant investigation.</p>","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":" ","pages":"308-314"},"PeriodicalIF":14.8000,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Comprehensive Cancer Network","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6004/jnccn.2023.7112","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Recent modifications to low-dose CT (LDCT)-based lung cancer screening guidelines increase the number of eligible individuals, particularly among racial and ethnic minorities. Because these populations disproportionately live in metropolitan areas, we analyzed the association between travel time and initial LDCT completion within an integrated, urban safety-net health care system.

Methods: Using Esri's StreetMap Premium, OpenStreetMap, and the r5r package in R, we determined projected private vehicle and public transportation travel times between patient residence and the screening facility for LDCT ordered in March 2017 through December 2022 at Parkland Memorial Hospital in Dallas, Texas. We characterized associations between travel time and LDCT completion in univariable and multivariable analyses. We tested these associations in a simulation of 10,000 permutations of private vehicle and public transportation distribution.

Results: A total of 2,287 patients were included in the analysis, of whom 1,553 (68%) completed the initial ordered LDCT. Mean age was 63 years, and 73% were underrepresented minorities. Median travel time from patient residence to the LDCT screening facility was 17 minutes by private vehicle and 67 minutes by public transportation. There was a small difference in travel time to the LDCT screening facility by public transportation for patients who completed LDCT versus those who did not (67 vs 66 min, respectively; P=.04) but no difference in travel time by private vehicle for these patients (17 min for both; P=.67). In multivariable analysis, LDCT completion was not associated with projected travel time to the LDCT facility by private vehicle (odds ratio, 1.01; 95% CI, 0.82-1.25) or public transportation (odds ratio, 1.14; 95% CI, 0.89-1.44). Similar results were noted across travel-type permutations. Black individuals were 29% less likely to complete LDCT screening compared with White individuals.

Conclusions: In an urban population comprising predominantly underrepresented minorities, projected travel time is not associated with initial LDCT completion in an integrated health care system. Other reasons for differences in LDCT completion warrant investigation.

城市安全网人群进行低剂量 CT 肺癌初次筛查的地理可达性和完成情况。
背景:最近对基于低剂量 CT(LDCT)的肺癌筛查指南的修改增加了符合条件的人数,尤其是在少数种族和少数民族中。由于这些人群大多居住在大都市地区,我们分析了在一个综合的城市安全网医疗保健系统中,旅行时间与首次完成 LDCT 之间的关联:我们使用 Esri 的 StreetMap Premium、OpenStreetMap 和 R 中的 r5r 软件包,确定了 2017 年 3 月至 2022 年 12 月德克萨斯州达拉斯帕克兰纪念医院患者住所与 LDCT 筛查机构之间的预计私家车和公共交通旅行时间。我们在单变量和多变量分析中描述了旅行时间与 LDCT 完成之间的关联。我们模拟了 10,000 种私家车和公共交通的分布情况,对这些关联进行了测试:共有 2,287 名患者参与了分析,其中 1,553 人(68%)完成了最初订购的 LDCT。平均年龄为 63 岁,73% 为代表性不足的少数民族。从患者住所到 LDCT 筛查机构的中位旅行时间为:乘私家车 17 分钟,乘公共交通工具 67 分钟。完成 LDCT 的患者与未完成 LDCT 的患者乘坐公共交通前往 LDCT 筛查机构所需的时间差异较小(分别为 67 分钟 vs 66 分钟;P=.04),但这些患者乘坐私家车前往 LDCT 筛查机构所需的时间没有差异(均为 17 分钟;P=.67)。在多变量分析中,完成 LDCT 与预计乘坐私家车(几率比为 1.01;95% CI,0.82-1.25)或公共交通(几率比为 1.14;95% CI,0.89-1.44)前往 LDCT 设施的旅行时间无关。在不同的旅行类型中也发现了类似的结果。与白人相比,黑人完成 LDCT 筛查的可能性要低 29%:结论:在主要由代表性不足的少数族裔组成的城市人口中,预计旅行时间与综合医疗系统中最初的 LDCT 完成率无关。导致 LDCT 筛查完成率差异的其他原因值得研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
20.20
自引率
0.00%
发文量
388
审稿时长
4-8 weeks
期刊介绍: JNCCN—Journal of the National Comprehensive Cancer Network is a peer-reviewed medical journal read by over 25,000 oncologists and cancer care professionals nationwide. This indexed publication delivers the latest insights into best clinical practices, oncology health services research, and translational medicine. Notably, JNCCN provides updates on the NCCN Clinical Practice Guidelines in Oncology® (NCCN Guidelines®), review articles elaborating on guideline recommendations, health services research, and case reports that spotlight molecular insights in patient care. Guided by its vision, JNCCN seeks to advance the mission of NCCN by serving as the primary resource for information on NCCN Guidelines®, innovation in translational medicine, and scientific studies related to oncology health services research. This encompasses quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship. JNCCN boasts indexing by prominent databases such as MEDLINE/PubMed, Chemical Abstracts, Embase, EmCare, and Scopus, reinforcing its standing as a reputable source for comprehensive information in the field of oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信